Frontlight ResearchEarly access
CompletedPhase 4
MyKid-study: a study to examine the effect and safety of an injection of Mydrane® into the eye of children who will undergo cataract surgery
Key facts
- Who runs it
- Antwerp University Hospital
- Where
- Belgium1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 40 people enrolled
- Started
- 1 Jul 2023
- Ended
- 17 Sept 2025
- Type of study
- Interventional
- Record updated
- 28 November 2023
Who can take part
- Age
- Up to 17 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Children aged 8 weeks to 17 years old who are scheduled for surgical cataract repair of one or both eyes
Who cannot take part
- patients who previously had cataract surgery of one eye within this study and receive surgery of the contralateral eye on a different day
- Patients with a reported allergy for one of the components of Mydrane®
- Patients younger than 8 weeks
- Patients who are pregnant. Girls of childbearing age will be tested for pregnancy with urinary analysis (hCG) at the time of inclusion
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Evaluation of the efficacy and safety of the use of Mydrane in children
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- MyKid-study: efficacy and systemic side effects of intracameral Mydrane® injections in children undergoing cataract surgery.
- Record updated
- 28 November 2023